Related Experiment Video
Updated: Nov 21, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Coxsackievirus B3 Infection Early in Pregnancy Induces Congenital Heart Defects Through Suppression of Fetal
Vipul Sharma1, Lisa S Goessling1, Anoop K Brar1
1Division of Pediatric Cardiothoracic Surgery Department of Surgery Washington University School of Medicine St. Louis MO.
Insights
Prenatal Coxsackievirus B3 infection during early gestation can cause congenital heart defects in fetuses. This viral exposure impacts cardiomyocyte proliferation and cardiac development, leading to conditions like ventricular septal defects.
Area of Science:
- Cardiovascular Research
- Developmental Biology
- Virology
Background:
- Coxsackievirus B (CVB) is a leading cause of viral myocarditis.
- The coxsackie and adenovirus receptor, targeted by CVB, is highly expressed in the fetal heart.
- Prenatal CVB3 infection is hypothesized to cause congenital heart defects (CHDs) during critical gestational windows.
Purpose of the Study:
- To investigate if Coxsackievirus B3 (CVB3) infection during early gestation precipitates congenital heart defects in a mouse model.
- To determine the critical window of gestation and dose-response relationship for CVB3-induced CHDs.
- To elucidate the molecular mechanisms underlying CVB3-induced cardiac malformations.
Main Methods:
- Pregnant C57Bl/6 mice were infected with CVB3 at embryonic days 5, 7, 9, and 11.
- Different viral titers were used to assess dose-response effects and viral loads in fetal organs.
- RNA sequencing, KEGG pathway analysis, and immunohistochemistry were employed to study signaling pathways in affected fetal hearts.
Main Results:
- CVB3 exposure between embryonic days 7 and 9 resulted in CHDs, including ventricular septal defects (33.6%), noncompaction-like architecture (23.5%), and double-outlet right ventricle (4.4%).
- A direct correlation was observed between viral titers and CHD severity, with a higher incidence in female fetuses.
- CVB3-infected fetuses with VSDs showed significantly reduced cardiomyocyte proliferation (50% lower) and altered Hippo, tight junction, TGF-β1, and ECM signaling pathways.
Conclusions:
- Prenatal CVB3 infection is a causative factor for congenital heart defects.
- Reduced cardiomyocyte proliferation and subsequent alterations in cardiac architecture and trabeculation are key mechanisms driving CVB3-induced CHDs.
- Maternal health and placental integrity were unaffected, indicating direct fetal cardiac effects are responsible for CHDs.
Abstract:
Background Coxsackievirus B (CVB) is the most common cause of viral myocarditis. It targets cardiomyocytes through coxsackie and adenovirus receptor, which is highly expressed in the fetal heart. We hypothesized CVB3 can precipitate congenital heart defects when fetal infection occurs during critical window of gestation. Methods and Results We infected C57Bl/6 pregnant mice with CVB3 during time points in early gestation (embryonic day [E] 5, E7, E9, and E11). We used different viral titers to examine possible dose-response relationship and assessed viral loads in various fetal organs. Provided viral exposure occurred between E7 and E9, we observed characteristic features of ventricular septal defect (33.6%), abnormal myocardial architecture resembling noncompaction (23.5%), and double-outlet right ventricle (4.4%) among 209 viable fetuses examined. We observed a direct relationship between viral titers and severity of congenital heart defects, with apparent predominance among female fetuses. Infected dams remained healthy; we did not observe any maternal heart or placental injury suggestive of direct viral effects on developing heart as likely cause of congenital heart defects. We examined signaling pathways in CVB3-exposed hearts using RNA sequencing, Kyoto Encyclopedia of Genes and Genomes enrichment analysis, and immunohistochemistry. Signaling proteins of the Hippo, tight junction, transforming growth factor-β1, and extracellular matrix proteins were the most highly enriched in CVB3-infected fetuses with ventricular septal defects. Moreover, cardiomyocyte proliferation was 50% lower in fetuses with ventricular septal defects compared with uninfected controls. Conclusions We conclude prenatal CVB3 infection induces congenital heart defects. Alterations in myocardial proliferate capacity and consequent changes in cardiac architecture and trabeculation appear to account for most of observed phenotypes.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Valve Prolapse III: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Teratogenicity
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy

